acetyl l carnitine interactions with supplements metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney disease treatment Revisiting the Role of Carnitine
Description
doi: 10.1021/ol000173t 332 OglahMKMustafaYF
cuspidatum extract showed an IC 50 value of 0.18 g/mL, inhibiting the interaction between the PDGF-BB molecule and its receptor, PDGFR-
Feng et al., 2009
10.1104/pp.001362 67 PanchukI
